These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 1318338
21. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. James SL, Glaven J. J Immunol; 1989 Dec 15; 143(12):4208-12. PubMed ID: 2592772 [Abstract] [Full Text] [Related]
22. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. Leu RW, Leu NR, Shannon BJ, Fast DJ. J Immunol; 1991 Sep 15; 147(6):1816-22. PubMed ID: 1909732 [Abstract] [Full Text] [Related]
23. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O'Donnell CA, Liew FY, Moncada S. Eur J Immunol; 1994 Mar 15; 24(3):672-6. PubMed ID: 8125136 [Abstract] [Full Text] [Related]
24. Generation of nitric oxide inhibits formation of superoxide in macrophages during activation. Jun CD, Lee JY, Lee BS, Choi BM, Um JY, Kwak HJ, Jl KY, Kim HM, Chung HT. Biochem Mol Biol Int; 1994 Aug 15; 34(1):1-8. PubMed ID: 7849611 [Abstract] [Full Text] [Related]
25. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. Martin JH, Edwards SW. J Immunol; 1993 Apr 15; 150(8 Pt 1):3478-86. PubMed ID: 8385686 [Abstract] [Full Text] [Related]
26. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Denis M, Chadee K. Infect Immun; 1989 Jun 15; 57(6):1750-6. PubMed ID: 2542164 [Abstract] [Full Text] [Related]
27. Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells. Isobe K, Nakashima I. Biochem Biophys Res Commun; 1993 Apr 30; 192(2):499-504. PubMed ID: 8484761 [Abstract] [Full Text] [Related]
28. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma. Jun CD, Yoon HJ, Kim HM, Chung HT. Biochem Biophys Res Commun; 1995 Jan 26; 206(3):969-74. PubMed ID: 7832812 [Abstract] [Full Text] [Related]
29. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. Adams LB, Hibbs JB, Taintor RR, Krahenbuhl JL. J Immunol; 1990 Apr 01; 144(7):2725-9. PubMed ID: 2319133 [Abstract] [Full Text] [Related]
30. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. Albina JE, Abate JA, Henry WL. J Immunol; 1991 Jul 01; 147(1):144-8. PubMed ID: 1904899 [Abstract] [Full Text] [Related]
31. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Wang W, Keller K, Chadee K. Immunology; 1994 Dec 01; 83(4):601-10. PubMed ID: 7533135 [Abstract] [Full Text] [Related]
32. Production of nitric oxide by murine bone marrow cells. Inverse correlation with cellular proliferation. Punjabi CJ, Laskin DL, Heck DE, Laskin JD. J Immunol; 1992 Sep 15; 149(6):2179-84. PubMed ID: 1517578 [Abstract] [Full Text] [Related]
33. Catalase inhibits nitric oxide synthesis and the killing of intracellular Leishmania major in murine macrophages. Li Y, Severn A, Rogers MV, Palmer RM, Moncada S, Liew FY. Eur J Immunol; 1992 Feb 15; 22(2):441-6. PubMed ID: 1537380 [Abstract] [Full Text] [Related]
34. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. Feder LS, Laskin DL. J Leukoc Biol; 1994 Apr 15; 55(4):507-13. PubMed ID: 8145021 [Abstract] [Full Text] [Related]
35. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. Hibbs JB, Vavrin Z, Taintor RR. J Immunol; 1987 Jan 15; 138(2):550-65. PubMed ID: 2432129 [Abstract] [Full Text] [Related]
36. The role of nitric oxide as an effector of macrophage-mediated cytotoxicity against Trichomonas vaginalis. Park GC, Ryu JS, Min DY. Korean J Parasitol; 1997 Sep 15; 35(3):189-95. PubMed ID: 9335184 [Abstract] [Full Text] [Related]
37. Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization. Denis M, Chadee K. Immunology; 1989 Jan 15; 66(1):76-82. PubMed ID: 15493266 [Abstract] [Full Text] [Related]
38. Taxol provides a second signal for murine macrophage tumoricidal activity. Manthey CL, Perera PY, Salkowski CA, Vogel SN. J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736 [Abstract] [Full Text] [Related]
39. Activated mouse macrophages kill Entamoeba histolytica trophozoites by releasing reactive nitrogen intermediates. Denis M, Ghadirian E. Microb Pathog; 1992 Mar 15; 12(3):193-8. PubMed ID: 1614330 [Abstract] [Full Text] [Related]
40. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release. Bernard C, Szekely B, Philip I, Wollman E, Payen D, Tedgui A. J Clin Invest; 1992 Mar 15; 89(3):851-60. PubMed ID: 1541677 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]